[1]
“Early Stage Clinical Trial of Ginger (Zingiber officinale) as an Add-on Antiepileptic Therapy in Children with Generalized Epilepsies”, KJPS, vol. 1, no. 1, Aug. 2021, doi: 10.53332/kjps.v1i1.38.